Strategic information disclosure, integrated reporting and the role of intellectual capital

A theoretical and empirical model is used to investigate the adoption of the integrated reporting (IR) framework as a strategic choice to signal intellectual capital (IC) to equity investors, with specific reference to the pharmaceutical industry.